<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116449</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02397-50</org_study_id>
    <nct_id>NCT05116449</nct_id>
  </id_info>
  <brief_title>Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein)</brief_title>
  <acronym>IDSein</acronym>
  <official_title>Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to explore the quality of life of cancer patients, in particular&#xD;
      women operated on breast cancer, throughout their care journey, taking into account their&#xD;
      access to supportive oncological care within and outside the establishment care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2021</start_date>
  <completion_date type="Anticipated">August 22, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 22, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life questionnaire : FACT-B</measure>
    <time_frame>12 months</time_frame>
    <description>Functional Assessment of Cancer Therapy-breast : 27 items about physical well-being, family well-being, emotional and functional well-being. The quotation is between 0 &quot;not at all&quot; and 4 &quot;verry much&quot;. The total score is between 0 and 148.&#xD;
The higher the scores, the higher the QoL and the various well-being.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life questionnaire : EORTC QLQ-C30</measure>
    <time_frame>12 months</time_frame>
    <description>30 items for all patient suffering from cancer. The answer of each question is between 1 &quot;not at all&quot; and 4 &quot;very much&quot;</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>Patient seeking supportive care</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient without any supportive care</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Quality of life questionnaires</intervention_name>
    <description>Different quality of life questionnaires : FACT-B, EORTC QLQ-C30, QIC, BRIEF COPE, HADS, QSSS-C</description>
    <arm_group_label>Patient seeking supportive care</arm_group_label>
    <arm_group_label>Patient without any supportive care</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women patient with breast cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Woman with histologically confirmed invasive breast cancer for whom surgery is&#xD;
             scheduled&#xD;
&#xD;
          -  Age&gt; 18 years old&#xD;
&#xD;
          -  Performance status ECOG &lt;2&#xD;
&#xD;
          -  Patient speaking and understanding French and able to complete questionnaires&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme&#xD;
&#xD;
          -  Patient having read the information note and not objecting to the use of the data&#xD;
             collected&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  male&#xD;
&#xD;
          -  Patient treated with neoadjuvant chemotherapy&#xD;
&#xD;
          -  Patient participating in a therapeutic trial&#xD;
&#xD;
          -  Patient with metastatic breast cancer&#xD;
&#xD;
          -  Patient with bilateral breast cancer&#xD;
&#xD;
          -  History of cancer of less than 5 years&#xD;
&#xD;
          -  Active infection or other serious underlying condition that may prevent the patient&#xD;
             from receiving treatment&#xD;
&#xD;
          -  History or progressive psychiatric illness&#xD;
&#xD;
          -  Person deprived of liberty or under guardianship&#xD;
&#xD;
          -  Inability to undergo medical monitoring for geographical, social or psychological&#xD;
             reasons Indication of emergency amputation&#xD;
&#xD;
          -  Protected patient: adult under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman&#xD;
&#xD;
          -  Patient hospitalized without consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut du sein Drôme Ardèche</name>
      <address>
        <city>Guilherand-Granges</city>
        <zip>07500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Oudet</last_name>
      <phone>0683346567</phone>
      <email>jf.oudet@ecten.eu</email>
    </contact>
    <contact_backup>
      <last_name>Marie-Hélène Barba</last_name>
      <email>mh.barba@ecten.eu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

